Head-to-head comparison
REMEVi vs Vea Health
Two GLP-1 providers, one scorecard. Both are graded on the same six Desk Score dimensions — here is how they stack up, and which one fits you.
Desk Score
A flat $219 a month for semaglutide and $319 for tirzepatide at every dose, lower on 12- and 24-week plans, with four named pharmacies and the whole program in English or Spanish.
$219/mo sema · $319/mo tirz · Verified August 2026
Marked down on: The flat rate is a higher entry price than teaser-led competitors
Desk Score
Vea Health is a direct-to-consumer telehealth platform aimed at men's health, performance, and longevity, offering compounded semaglutide and tirzepatide in both oral and injection protocols.
Marked down on: Pricing not shown until after sign-up
REMEVi takes this head-to-head with the higher Desk Score, 86/100 (B) against 60/100 (C) for Vea Health. Vea Health still holds its ground where its strengths line up with yours.
Desk Score, dimension by dimension
Same six measured dimensions for both. The red flag marks the stronger side. See the methodology.
REMEVi
86/100
B
Vea Health
60/100
C
Price transparency
State access
Molecule range
Onboarding speed
Support responsiveness
Licensing & trust
The spec sheet
| Field | REMEVi | Vea Health |
|---|---|---|
| Semaglutide | $219/mo$219/mo month-to-month; $189/mo on a 12-week plan; $179/mo on a 24-week plan; same price at every dose; oral tablet $349/mo month-to-month or $309/mo on a 12-week plan | Not listed on Vea Health's site (checked June 2026) |
| Tirzepatide | $319/mo$319/mo month-to-month; $249/mo on a 12-week plan; $229/mo on a 24-week plan; same price at every dose; compounded injectable | Not listed on Vea Health's site (checked June 2026) |
| Coverage | All 50 states and DC | All 50 states |
| Brand-name | Compounded only | Compounded only |
| Oral option | Yes | Yes |
| Best for | Someone who wants one price that never climbs with the dose — or a Spanish-speaking patient who wants the intake, portal and care team in their own language. | Men's-health-focused oral and injectable compounded GLP-1. |
| Desk Score | 86/100B | 60/100C |
The verdict
Desk pick — REMEViREMEVi takes this head-to-head with the higher Desk Score, 86/100 (B) against 60/100 (C) for Vea Health. Vea Health still holds its ground where its strengths line up with yours.
Choose REMEVi if…
Someone who wants one price that never climbs with the dose — or a Spanish-speaking patient who wants the intake, portal and care team in their own language.
$219/mo sema · $319/mo tirz · All 50 states and DC
Choose Vea Health if…
Men's-health-focused oral and injectable compounded GLP-1.
All 50 states
Assume any provider we list may compensate us — we may earn a referral commission at no extra cost to you, and what we write about a provider reads the same either way. Read full breakdowns: REMEVi · Vea Health.
Also here
CoreAge Rx leads the whole ranking at 94/100
Whichever of these two you lean toward, our #1-rated provider outscores them both. One price at every dose, both molecules, all 50 states. The $99 and $149 figures are 12-month plans paid up front, not a monthly bill.
More head-to-heads
- CoreAge Rx vs REMEVi
- CoreAge Rx vs Vea Health
- Curex vs REMEVi
- Strut Health vs Vea Health
- BetterMe Rx vs REMEVi
- Curex vs Vea Health
Or see the full comparison hub and the complete ranking.
Pricing and verification reflect each provider's public disclosures at last scoring; the Desk Score is our editorial judgment per the methodology. Prices change — confirm on each provider's own site. Not medical advice; see our disclosure.